Crossmark

Mechanism of Asperosaponin VI Related to EGFR/MMP9/AKT/PI3K Pathway in Treatment of Rheumtoid Arthritis

Published Online: 2024-11-05

Published Print: 2025-02

Authors

Luo, Jin-fang

Yu, Yang

Liu, Jian-xin
License Information

Text and Data Mining valid from 2024-11-05

Version of Record valid from 2024-11-05
More Information

Article History

Accepted: 10 May 2024

First Online: 5 November 2024

Conflict of Interest

: The authors declare that there is no conflict of interest regarding the publication of this article.

Document is current